Fundamentals | Research Roadmap
Join the Research Listserv

OneTrust

Dec 22, 2021 | IT Systems Internal

Purpose The OneTrust platform centralizes the cybersecurity risk assessment process for clinical applications and research studies. This procedure provides step-by-step instructions on how to request a Third-Party Risk Assessment and track its process using the...

Leaf

Nov 2, 2021 | IT Systems Internal

Leaf is a drag-and-drop tool that enables you to easily create patient cohorts from de-identified data using multiple clinical and demographic criteria.

Gift – GCO

Jul 13, 2021 | Glossary

A gift is the voluntary, non-reciprocal transfer of money or property from a donor to an institution. The donor may be an individual, a corporation or a non-profit organization. The donor does not expect anything of value in return other than recognition and does not have control over expenditure of the funds. A gift may meet the interests of the donor and can be restricted or unrestricted.

eSafety

Apr 27, 2021 | IT Systems Internal

Purpose eSafety is a biosafety protocol management portal. Key features of eSafety are: Smart-forms System rapidity and stability Protocol copy function for easy duplication of protocols Integration with eIACUC to link research animal protocols requiring biosafety...

Academic Research Organization (ARO) Agreements

Apr 20, 2021 | Agreement Navigator

ARO agreements are formal, written contracts between the Icahn School of Medicine at Mount Sinai and commercial or other biomedical entities. These agreements encourage scientific inquiry and collaboration, and enable faculty, as part of their employment by the School, to provide research-related expertise as defined below, and to assume leadership roles in industry-funded studies or research entities.

Dean’s Office Announcements

Apr 19, 2021 | Fundamentals

Controlled Substance Policy (1/8/2024) Any PI who needs a controlled substance of any schedule for use in animals, cells, or in vitro must either get his/her own license or collaborate with another PI who has such a license and is willing to oversee use of the drug...